跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,507 条关于
“Factor Xa inhibitors”
全部
26,507
临床试验
15,555
药物
4,130
机构
42
资讯
6,780
29天前
VarmX Enrolls First Participant in Global Phase 3 EquilibriX-S Trial of VMX-C001 for Urgent Surgery
去年
Andexanet Alfa's Clinical Benefit Questioned by FDA Panel Despite Hematoma Control
9个月前
AstraZeneca Voluntarily Withdraws Andexxa from US Market Following Fatal Thromboembolic Events
去年
AstraZeneca's Andexxa Faces Uncertain Future After Failure to Secure Full FDA Approval
去年
FDA Denies Full Approval for Andexxa Following Dosing Uncertainties
3年前
VarmX Secures €30M Series B2 Funding to Advance Anticoagulation Reversal Drug VMX-C001 Toward Pivotal Trial
去年
The Future of Factor XI Inhibitors in Atrial Fibrillation Treatment
去年
CRISPR Therapeutics Expands into siRNA Therapies with $95M Sirius Partnership for Thromboembolic Disorders
去年
Talus Bio Unveils Promising Preclinical Data on Novel Transcription Factor Inhibitors at AACR 2025
去年
Cadrenal Therapeutics Acquires eXIthera's Factor XIa Inhibitor Portfolio in $15M Deal
第 1 页,共 678 页
上一页
下一页